BioMarin Reports Positive Trial Results
BioMarin Pharmaceutical Inc. (BMRN) reported positive clinical trial results for its metabolic disorder treatment Phenoptin. The stock price climbed $1.47 to close at $13.92.
posted by FC Market News at 9:55 AM
0 Comments:
Post a Comment
<< Home